Bio4t2 announces first patient infused with CAR-T targeting solid tumors

SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Bio4t2 dosed the first patient with T cells bearing a chimeric antigen receptor (CAR) that targets overex...

Related Keywords

China ,United States ,Shanghai ,Farzad Haerizadeh ,Prnewswire Bio ,Jenny Bourbiel ,Bridgewest Group ,Laurence Cooper ,Executive Chairman ,Chief Scientific Officer ,Haerizadeh About ,Shanghai East ,Shanghai Artemed ,